Counterpoint Mutual Funds’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,212
Closed -$506K 442
2025
Q4
$506K Buy
+35,212
New +$609K 0.04% 107
2024
Q4
Sell
-24,598
Closed -$522K 378
2024
Q3
$522K Buy
24,598
+2,485
+11% +$44.8K 0.1% 73
2024
Q2
$350K Sell
22,113
-26,881
-55% -$494K 0.08% 111
2024
Q1
$729K Buy
48,994
+23,960
+96% +$328K 0.18% 9
2023
Q4
$229K Sell
25,034
-12,714
-34% -$87.7K 0.09% 41
2023
Q3
$210K Buy
37,748
+11,414
+43% +$79.9K 0.18% 56
2023
Q2
$212K Sell
26,334
-21,076
-44% -$155K 0.2% 51
2023
Q1
$310K Buy
+47,410
New +$194K 0.27% 6
2022
Q4
Sell
-19,845
Closed -$99K 390
2022
Q3
$99K Buy
+19,845
New +$116K 0.24% 197

Other funds holding OSCR

Counterpoint Mutual Funds's OSCR Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of Oscar Health (OSCR) in Q1 2026, closing a stake of 35,212 shares — an estimated $506K sold.

Counterpoint Mutual Funds first reported a position in OSCR in Q3 2022 and held it in 9 quarters. The position peaked at $729K in Q1 2024. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Counterpoint Mutual Funds reported no remaining Oscar Health position as of Q1 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 35,212 Oscar Health shares in Q1 2026, an estimated $506K.
  • Counterpoint Mutual Funds first reported a position in Oscar Health in Q3 2022 and held it in 9 quarters.
  • Counterpoint Mutual Funds's Oscar Health position peaked at $729K in Q1 2024.
  • 330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.